Biotech Investors & VC Firms in Asia-Pacific
68 firms in this list, with a median first check of $770K. 1 of them lead rounds. Generated from verified public data and updated continuously.
Cathay Health
ParisSeed–Late Stage
2 people
Diamond Biofund
TaipeiSeed–Series A
2 people
ePlanet Capital
San JoseSeed–Late Stage
2 people
Kama Flow
MoscowSeed–Late Stage
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Metaplanet
TallinnSeed–Series A
2 people
Mizuho Capital
TokyoSeed–Late Stage
1 person
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
AddVentures by SCG
BangkokSeed–Late Stage
1 person
Advantech Capital
BeijingGrowth–Late Stage
1 person
DCI Partners Co. Ltd.
TokyoSeed–Growth
1 person
Majuven
Seed–Late Stage
1 person
NSG Ventures
Seed–Series A
1 person
Panacea Venture
ShanghaiSeries A–Late Stage
1 person
SAV (Scale Asia Ventures)
Palo AltoSeed–Series B
1 person
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
1 person
TAYA Venture Capital
New Taipei CitySeed–Series A
1 person
YF Capital
ShanghaiSeed–Growth
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
CBC Group
SingaporeSeed–Late Stage
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.